Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Inverse probability weighted Cox proportional hazards regression models were used to assess the effect of glycosphingolipids levels on the risk of developing MA (albumin excretion rate ≥300 mg/24 hours) or CKD (glomerular filtration rate <60 mL/min) over a period of 21 to 28 years.
|
31043336 |
2020 |
Chronic Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
There was a U-shaped association between SAlb levels and risk of CKD development among general hypertensive patients with normal renal function and without CVD, with a turning point at about 51.4 g/L.
|
30799192 |
2020 |
Chronic Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Furthermore, differences were found in the quantity of hemoglobin (92.5 ± 16.8 vs 107.5 ± 18.3, P < 0.001) and albumin (32.4 ± 4.1 vs 34.9 ± 5.5, P = 0.02) measured between CKD and non-CKD patients.
|
30894199 |
2019 |
Chronic Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
After controlling for multiple confounding factors, prevalences of CKD (P < 0.001) and urinary albumin levels (P = 0.013) showed significantly increasing trends, whereas eGFR levels were markedly decreased from groups 1 to 4 (P < 0.001).
|
30928248 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Thus, we investigated the association of WG and RG with urinary albumin to creatinine ratio (ACR) and prevalent chronic kidney disease (CKD).
|
30375292 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Using Cox regression analysis, hazard ratios (HRs) were estimated after adjusting for the following covariates: age, sex, diabetes mellitus, diabetic nephropathy, cardiovascular disease, anemia, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists, loop diuretics, cigarette smoking, body mass index, serum albumin, systolic blood pressure, urine albumin-to-creatinine ratio, and CKD stage.
|
30168046 |
2019 |
Chronic Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Anemia in children with CKD was associated with older age, low body weight and body mass index (BMI) z-score, birth age, preceding glomerulonephritis, decreased estimated glomerular filtration rate (eGFR), low levels of serum albumin and calcium, high levels of serum intact parathyroid hormone (iPTH), and serum phosphorus.
|
30700016 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Association between Albumin-Globulin Ratio and Mortality in Patients with Chronic Kidney Disease.
|
31731708 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
In the whole study population, no difference in albumin excretion rate (AER) was observed between presence/absence of DR; instead, AER was significantly higher among patients with glomerular filtration rate (eGFR) < 60 mL/min/1.73 m<sup>2</sup> (CKD) (p = 0.009), above all in those with CKD and AER ≥0.03 g/24 h (p = 0.005).
|
31377186 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
The diagnosis of CKD was assessed by the estimated glomerular filtration rate (eGFR) or urinary albumin creatinine ratio (ACR).
|
31664172 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
We examined the urine levels of 5MedC in spot urine samples from 308 patients with CKD (median age: 56 years, male: 53.2%, and glomerulonephritis: 51.0%) using a competitive enzyme-linked immunosorbent assay and investigated the relationships among urine 5MedC, urine albumin, urine <i>α</i>1-microglobulin (<i>α</i>1MG), and the laboratory parameters associated with CKD.
|
31354889 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
With ISEL as our primary exposure variable, we performed multivariable regression models to evaluate the association between social support and prevalent CKD [estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2 or urine albumin-creatinine ratio (ACR) ≥30 mg/g], eGFR decline, and rapid renal function decline (RRFD) (> 30% decrease in eGFR over approximately 10 years).
|
31307430 |
2019 |
Chronic Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Pharmacologic inhibition of miR-214 had a similar effect in the albumin overload model of CKD.
|
30955870 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Unadjusted and adjusted proportional hazards models were fit to estimate the association of impaired fasting glucose (versus normoglycemia) with a composite outcome of worsening kidney function (≥30% decrease in eGFR to <60 ml/min/1.73 m2 in participants without baseline CKD; ≥50% decrease in eGFR or need of long-term dialysis/kidney transplantation in participants with CKD) or incident albuminuria (doubling of urinary albumin to creatinine ratio from <10 mg/g to >10 mg/g).
|
31063197 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Multivariable sub-distribution hazards model identified serum albumin (SHR 0.48; 95% CI 0.35-0.67), hemoglobin A1c (SHR 0.71; 95% CI 0.54-0.94), eGFR (SHR 0.98; 95% CI 0.97-0.99), urinary albumin/creatinine ratio (UACR) (SHR 1.18; 95% CI 1.08-1.29), percentage of segmental/global glomerulosclerosis (%GS) (SHR 1.01; 95% CI 1.00-1.02) and interstitial fibrosis and tubular atrophy (IFTA) (SHR 1.52; 95% CI 1.20-1.92) as risk factors for CKD progression.
|
29788462 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
The GNRI was calculated by incorporating serum albumin and anthropometric measurements in 326 patients with nondialysis stage 3-5 CKD who were followed up from September 2011 to March 2017 for end-stage renal disease (ESRD) and the composite outcome of all-cause death and cardiovascular events.
|
31739530 |
2019 |
Chronic Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In addition, the likelihood of self-reporting a balance and falling problem in the past year was higher in persons who had advanced CKD, were of older age, were of female sex, were with former or current smoking status, had lower 25(OH)D levels, and had lower albumin levels.
|
30581062 |
2019 |
Chronic Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients.
|
31234687 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report.
|
31070491 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
We aimed to evaluate the association between sodium intake and fractional albumin and immunoglobulin G (IgG) excretion in nondialytic CKD.
|
31216544 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
However, urinary albumin was ≈60% less and left ventricular mass was ≈40% less in the CKD sheep that underwent RDN compared with intact counterpart.
|
30661475 |
2019 |
Chronic Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The number of the remaining teeth in prosthesis group affected the serum albumin levels of CKD patients.
|
31381241 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Analysis of 2DE found significantly altered abundance of five protein candidates between HIV-infected patients with non-proteinuric CKD and without CKD: alpha-1-microglobulin (A1M), serum albumin (ALB), zinc-alpha-2-glycoprotein (AZGP1), haptoglobin (HP), and retinol binding protein (RBP4).
|
31401122 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Patients with CKD had a median eGFR of 48.9 mL/min/1.73 m<sup>2</sup> and 51.2% had a urinary albumin level ≥ 30 mg/g.
|
30878037 |
2019 |
Chronic Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
PEDF was evaluated in relation to subsequent cardiovascular outcomes, mortality, and renal dysfunction (defined as urinary albumin creatinine ratio (ACR) ≥300 mg/g), or chronic kidney disease (CKD) stages 3 (eGFR<60 ml/min) or 4 (eGFR<60 and <30 ml/min respectively).
|
31434620 |
2019 |